Skip to content
Search

Latest Stories

RPS addresses Guild Council's concerns on Royal College proposal

RPS addresses Guild Council's concerns on Royal College proposal

The RPS intends to present the final proposal to establish a Royal College of Pharmacy for a vote in early 2025  

The Royal Pharmaceutical Society (RPS) has responded to the concerns raised by the Guild of Healthcare Pharmacists (GHP) about their proposals to become a Royal College.

On behalf of the Guild Council, Rob Connah, president of GHP, recently wrote an open letter to the RPS seeking clarity on the potential impacts of this transition on career progression, time commitments, and other relevant considerations.


In response to the Guild Council’s inquiries regarding credentialing, RPS chief executive Paul Bennett emphasised that the key purpose of credentialing is to “protect the public and the integrity of the pharmacy profession through assuring patient-focused pharmacists working at advancing levels of post-registration practice.”

“Defining and assuring post-registration professional standards is a fundamental activity for a royal college and thus fully aligned with our proposals for change,” he added.

The RPS highlighted the benefits that credentialing can provide both pharmacists and the system.

Paul explained: “For a pharmacist, credentialing can support a standard professional career structure that offers potential for advancement.

“Credentialing also engenders professional confidence and pride, increases professional cohesion and provides a mechanism by which the skills and capabilities of an individual are recognised.”

For the employer and wider system, he stressed that “credentialing provides an objective and validated assurance mechanism for employee capability within and across organisations which can inform fair and valid career progression and recruitment decisions, assure consistency across the system and improve workforce portability.”

Additionally, he noted that it provides a mechanism by which other health professionals and patients can recognise the level of practice of the pharmacy workforce.

The RPS indicated that for credentialing to be fully integrated into the profession, it needs to be integrated into job descriptions, job plans and career progression, while stating “We continue to drive for this through our advocacy work.”

The Guild Council have expressed concern that the current NHS ecosystem offers limited time for pharmacists to focus on professional development.

The RPS acknowledged that providing pharmacists with “the time, space and support to develop professional practice portfolios” is essential for integrating credentialing meaningfully in the profession.

In response to the Council’s query about how NHS leaders will be supported in advocating for additional time for pharmacists to complete their portfolios, the RPS mentioned their advocacy through the Protected Learning Time policy while recognising the need for more effective job planning.

Additionally, Paul noted that their intention to register as a charity will ensure appropriate external frameworks and scrutiny, helping them achieve their goal of advancing pharmacy science and practice with patient and public benefit as a priority.

The RPS is currently engaging with its members and the broader profession about its proposals to become a Royal College, which are being presented through a series of ‘roadshow’ events across Great Britain in October and November.

The RPS has also invited the Guild of Healthcare Pharmacists to discuss the proposed transition to Royal College status.

Paul said: “We look forward to constructive dialogue with the Guild Council over the coming months as we refine our proposals for change and prepare to set the final proposition before our membership for a vote in early 2025.”

All pharmacists and pharmaceutical scientists are also encouraged to attend the roadshow events and learn more about the proposed changes.

 

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less